General Dynamics Corp. (GD) Pops 2.92% for February 17

Equities Staff |

One of the S&P 500’s big winners for Wednesday February 17 was General Dynamics Corp. (GD) as the company’s stock climbed 2.92% to $135.35 on volume of 983,275 shares.

The stock opened at $132.24 and saw an intraday low of $132.24 and an intraday high of $135.37. All told, the day saw a per-share gain of $3.84. The stock’s average daily volume of 1.62 million and 311.16 million shares outstanding. General Dynamics Corp. now has a 50-day SMA is $133.93 and 200-day SMA is $140.09, and it has a 52-week high of $153.76 and a 52-week low of $121.61.

General Dynamics Corp is an aerospace and defense company. It offers products and services in business aviation; combat vehicles, weapons systems and munitions; shipbuilding; and communication and information technology services and solutions.

Based out of Falls Church, VA, General Dynamics Corp. has 99,900 employees and, after today’s trading, reached a market cap of $42.12 billion. The stock’s P/E Ratio is 14.5. Its P/S ratio is 1.3, P/B ratio is 3.92, and P/FCF ratio is 38.7.

For a complete fundamental analysis analysis of General Dynamics Corp., check out’s Stock Valuation Analysis report for GD. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets

Initial State

Initial State is an Internet of Things (IoT) data analytics & data management platform company. We turn sensor and event data into information that matters by making it easy to…

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…